产品说明
一般描述
Native very low density lipoproteins from human plasma. VLDL transports hepatic synthesized triglycerides and cholesterol. May counteract the inhibitory effect of glucocorticoids on arachidonic acid release and prostaglandin I2 formation in vascular smooth muscle cells. (Composition: 88-95% lipid; 5-12% protein. Note: 5 mg vial contains 1 mg of protein.)
A 5 mg vial contains ~1 mg of protein.
Native very low density lipoproteins from human plasma. VLDL transports liver-synthesized triglycerides and cholesterol. May counteract the inhibitory effect of glucocorticoids on arachidonic acid release and prostaglandin I2 formation in vascular smooth muscle cells. Composition: 88-95% lipid; 5-12% protein.
包装
5 mg in Plastic ampoule
Please refer to vial label for lot-specific concentration.
警告
Toxicity: Standard Handling (A)
其他说明
Petrichenko, I., et al. 1993. Biochim. Biophys. Acta1166, 183.
法律信息
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
产品性质
测定 | ≥95% (of total lipoprotein content, electrophoresis) |
质量水平 | 100 |
形式 | liquid |
manufacturer/tradename | Calbiochem® |
储存条件 | do not freeze |
运输 | wet ice |
储存温度 | 2-8℃ |
安全信息
储存分类代码 | 11 - Combustible Solids |
WGK | WGK 1 |
闪点(F) | Not applicable |
闪点(C) | Not applicable |
Sigma-Aldrich